Does FULVESTRANT Cause Tumour marker increased? 408 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 408 reports of Tumour marker increased have been filed in association with FULVESTRANT (FULVESTRANT). This represents 2.3% of all adverse event reports for FULVESTRANT.
408
Reports of Tumour marker increased with FULVESTRANT
2.3%
of all FULVESTRANT reports
34
Deaths
54
Hospitalizations
How Dangerous Is Tumour marker increased From FULVESTRANT?
Of the 408 reports, 34 (8.3%) resulted in death, 54 (13.2%) required hospitalization, and 9 (2.2%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FULVESTRANT. However, 408 reports have been filed with the FAERS database.
What Other Side Effects Does FULVESTRANT Cause?
Malignant neoplasm progression (3,221)
Fatigue (1,840)
Death (1,677)
Metastases to bone (1,525)
Nausea (1,510)
Neutropenia (1,486)
Metastases to liver (1,241)
Breast cancer metastatic (1,165)
Diarrhoea (1,163)
Dyspnoea (858)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
ANASTROZOLE (142)
Which FULVESTRANT Alternatives Have Lower Tumour marker increased Risk?
FULVESTRANT vs FURAZOLIDONE
FULVESTRANT vs FUROSEMIDE
FULVESTRANT vs FUROSEMIDE\SPIRONOLACTONE
FULVESTRANT vs FUSIDATE
FULVESTRANT vs FUSIDIC ACID